Alexion cuts ties with two Cambridge biotechs in reorganization
July 27, 2017 at 11:01 AM EDT
The Connecticut-based drugmaker said it was terminating partnership agreements with Moderna Therapeutics and Blueprint Medicines as part of an effort to trim down its pipeline.
